Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NXE | CRUS |
|---|---|---|
| Price | $9.07 | $121.35 |
| Change today | ▲ 0.78% | ▲ 0.15% |
| Market cap | $6.08B | $6.08B |
| Return, 3 months | -0.2% | -17.2% |
| Return, year to date | -1.4% | +2.4% |
| Return, 1 year | +0.3% | -5.2% |
| P/E (TTM) | -30.7 | 14.8 |
| P/B | 4.7 | 2.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 40 | 55 |
| 30-day volatility | 44.2% | 31.9% |
| Max drawdown, 1 year | -37.3% | -39.4% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
